These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18347427)

  • 61. Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.
    Zhang R; Zhang X; Ma B; Xiao B; Huang F; Huang P; Ying C; Liu T; Wang Y
    Cancer Gene Ther; 2016 Jun; 23(6):168-77. PubMed ID: 27080225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
    Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
    J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
    Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
    [TBL] [Abstract][Full Text] [Related]  

  • 64. E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice.
    Li Z; Ye Z; Zhang X; Zhang Q; Fan D; Zhang Y; Luo HR; Yuan X; Li Z; Xiong D
    Oncotarget; 2016 Aug; 7(32):51815-51828. PubMed ID: 27322080
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy.
    Heise C; Hermiston T; Johnson L; Brooks G; Sampson-Johannes A; Williams A; Hawkins L; Kirn D
    Nat Med; 2000 Oct; 6(10):1134-9. PubMed ID: 11017145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth.
    Yoon AR; Hong J; Yun CO
    Oncotarget; 2015 Oct; 6(33):34875-91. PubMed ID: 26430798
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
    Yang Y; Xu W; Peng D; Wang H; Zhang X; Wang H; Xiao F; Zhu Y; Ji Y; Gulukota K; Helseth DL; Mangold KA; Sullivan M; Kaul K; Wang E; Prabhakar BS; Li J; Wu X; Wang L; Seth P
    Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
    Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
    Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.
    Gonzalez-Pastor R; Goedegebuure PS; Curiel DT
    Cancer Gene Ther; 2021 May; 28(5):375-389. PubMed ID: 32951021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS.
    Rajecki M; Kangasmäki A; Laasonen L; Escutenaire S; Hakkarainen T; Haukka J; Ristimäki A; Kairemo K; Kangasniemi L; Kiljunen T; Joensuu T; Pesonen S; Hemminki A
    Mol Ther; 2011 Apr; 19(4):629-31. PubMed ID: 21455206
    [No Abstract]   [Full Text] [Related]  

  • 74. Adenovirus: teaching an old dog new tricks.
    Seymour LW; Fisher KD
    Hum Gene Ther; 2011 Sep; 22(9):1041-2. PubMed ID: 21932993
    [No Abstract]   [Full Text] [Related]  

  • 75. HPMA copolymers for masking and retargeting of therapeutic viruses.
    Fisher KD; Seymour LW
    Adv Drug Deliv Rev; 2010 Feb; 62(2):240-5. PubMed ID: 20005911
    [TBL] [Abstract][Full Text] [Related]  

  • 76. How do changes in tumor matrix affect the outcome of virotherapy?
    Cheng J; Sauthoff H; Hay JG
    Cancer Biol Ther; 2007 Feb; 6(2):290-2. PubMed ID: 17361094
    [No Abstract]   [Full Text] [Related]  

  • 77. Enhancing anti-cancer virotherapy with heat-shock protein-mediated immune response.
    Guo W; Fang B
    Cancer Biol Ther; 2008 Feb; 7(2):196-7. PubMed ID: 18347427
    [No Abstract]   [Full Text] [Related]  

  • 78. Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response.
    Ren Z; Ye X; Fang C; Lu Q; Zhao Y; Liu F; Liang M; Hu F; Chen HZ
    Cancer Biol Ther; 2008 Feb; 7(2):191-95. PubMed ID: 18073525
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.